Plicní hypertenze^*

Czech version

Authors: Hikmet Al-Hiti
Authors‘ workplace: Klinika kardiologie, IKEM, Praha
Published in: Reviz. posud. Lék., 17, 2014, č. 2-3, s. 48-51
Category: Review articles, original papers, case report

^*Prezentováno v Inovačním kurzu katedry posudkového lékařství IPVZ, Praha 12. 12. 2013.

Overview

Pulmonary hypertension is defined as an abnormal increase of blood pressure in pulmonary artery. It may occur in a specific damage of pulmonary vessels (pulmonary arterial hypertension) or within the framework of a secondary cause (chronic heart failure, respiratory disease, etc.)

Pulmonary arterial hypertension is caused by increased lung vascular resistance (pre-capillary form of pulmonary hypertension) with increased pressure if lung artery, increased pulmonary vascular resistance and normal blood pressure in the left atrium or in wedge (pulmonary artery wedge pressure). The mean age of the patients at the time of diagnosis is around 50 years with more frequent incidence in females. The uncured pulmonary arterial hypertension is a fatal disease.

Keywords:
arterial hypertension – pulmonary arterial hypertension – right sided catheterization

Sources

1. Romberg, E. Uber Sklerose der Lungen Arterie. Dtsch. Arch. Klin. Med., 48, s. 197–206.

2. Dresdale, D. T., Schultz, M., Nichrom, R. J. Primary pulmonary hypertension. I Clinical and hemodynamic study. Am. J. Med., 1951, 11, p. 686–705.

3. Wagenvoort, C. A., Wagenvoort, N. Primary pulmonary hypertension: a pathologic study of the lung vessels in 156 classically diagnose CASE. Circulation, 1970, 42, p. 1163–1184.

4. Moride, Y., Abenhaim, L., Xu, J. Epidemiology of pulmonary hypertension in primary pulmonary hypertension. In Rubin, L. J., Rich, S. editors: Primary Pulmonary Hypertension. 1997, p. 163–178.

5. Rich, S., Dantzker, D. R., Ayres, S. M. et al. Primary pulmonary hypertension. A national prospective study. Ann. Intern. Med., 1987, 107, p. 216–223.

6. Rich, S. Primary pulmonary hypertension: Executive Summary from the World Symposium, 1988.

7. Rubin, L. J. Primary pulmonary hypertension. N. Eng. J. Med., 1997, 336, p. 111–117.

8. Runo, J. R., Loyd, J. E. Primary pulmonary hypertension. Lancet, 2003, 361, p. 1533–1544.

9. Farber, H. W., Loscalzo, J. Pulmonary arterial hypertension. N. Eng. J. Med., 2004, 351, p. 1655–1665.

10. Galie, N., Simonnrau, G. The Fift World Symposium on Pulmonary Hypertension. JACC, 2013, Vol. 65, No 25, Suppl D.

11. Humbert, M., Sitbon, O., Chaouat, A. et al. Pulmoary arterial hypertension in France Results from a National Registry. Am. J. Respir. Crit. Care Med., 2006, 173, p. 1023–1030.

12. D’Alonzo, G. E., Barst, R. J., Ayres, S. M. et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med., 1991, 115, p. 343–349.

13. McLaughlin, V. V., Shillington, A., Rich, S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation, 2002, 106, p. 1477–1482.